← Back to Search

MRI System

GE OPTIMA MR430s with HDx/GE Electronics for Magnetic Resonance Imaging

N/A
Waitlist Available
Led By Beth M Kline-Fath, MD
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights

Study Summary

This trial is to study how effective and safe it is to use MRI on infants in the NICU.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With Adverse Events as Observed During and After Scanning.
Secondary outcome measures
Baseline Measurement for Days Old Will be Recorded.
Each Infant's Anatomy Scanned Will be Obtained.
Each Infant's Baseline Measurement for Weight Will be Recorded.

Trial Design

1Treatment groups
Experimental Treatment
Group I: MRI for NeonatesExperimental Treatment1 Intervention
MRI
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
GE OPTIMA MR430s with HDx/GE Electronics
2018
N/A
~390

Find a Location

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiLead Sponsor
815 Previous Clinical Trials
6,531,211 Total Patients Enrolled
Beth M Kline-Fath, MDPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati
1 Previous Clinical Trials
657 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies in the trial for participants?

"Clinicaltrials.gov indicates that this medical study, which first went live on February 11th 2018 and was last modified July 22nd 2022, is not recruiting patients currently. However, there are still 1 other trials open for participation at the moment."

Answered by AI
~54 spots leftby Apr 2025